| Christine C Rohl, | |
|
10010 Donald Powers Dr, Munster, IN 46321 | |
| (219) 934-4200 | |
| (219) 934-6240 |
| Full Name | Christine C Rohl |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 20 Years |
| Location | 10010 Donald Powers Dr, Munster, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083668909 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 71001907A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Hospitals Inc | Gary, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hansa Medical Groupe Llc | 5092881417 | 35 |
News Archive
American Oriental Bioengineering, Inc., ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced that 158 of the Company's drugs have been included in China's National (Medical) Insurance Catalog (the "2009 NIC").
The American Pain Foundation (APF), the nation's largest consumer advocacy organization for people in pain, released today a position statement imploring the medical community, regulators and concerned stakeholders to reaffirm their ethical commitment to the 76.5 million Americans—or one in four people—who struggle with pain, work collaboratively to improve access to pain care and dismantle the barriers preventing timely, appropriate and effective pain care for millions.
Neuralstem, Inc. announced that the first patients were dosed in Phase Ib of its ongoing trial to test the safety of NSI-189 in the treatment of major depressive disorder (MDD).
Public Health Week, April 7-13, annually highlights health promotion, disease prevention, and early intervention, but for the faculty and students at the Johns Hopkins University School of Nursing (JHUSON), every week is public health week.
› Verified 4 days ago
| Entity Name | The Methodist Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720290588 PECOS PAC ID: 9638063894 Enrollment ID: O20080805000003 |
News Archive
American Oriental Bioengineering, Inc., ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced that 158 of the Company's drugs have been included in China's National (Medical) Insurance Catalog (the "2009 NIC").
The American Pain Foundation (APF), the nation's largest consumer advocacy organization for people in pain, released today a position statement imploring the medical community, regulators and concerned stakeholders to reaffirm their ethical commitment to the 76.5 million Americans—or one in four people—who struggle with pain, work collaboratively to improve access to pain care and dismantle the barriers preventing timely, appropriate and effective pain care for millions.
Neuralstem, Inc. announced that the first patients were dosed in Phase Ib of its ongoing trial to test the safety of NSI-189 in the treatment of major depressive disorder (MDD).
Public Health Week, April 7-13, annually highlights health promotion, disease prevention, and early intervention, but for the faculty and students at the Johns Hopkins University School of Nursing (JHUSON), every week is public health week.
› Verified 4 days ago
| Entity Name | Hansa Medical Groupe Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386804615 PECOS PAC ID: 5092881417 Enrollment ID: O20151008002209 |
News Archive
American Oriental Bioengineering, Inc., ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced that 158 of the Company's drugs have been included in China's National (Medical) Insurance Catalog (the "2009 NIC").
The American Pain Foundation (APF), the nation's largest consumer advocacy organization for people in pain, released today a position statement imploring the medical community, regulators and concerned stakeholders to reaffirm their ethical commitment to the 76.5 million Americans—or one in four people—who struggle with pain, work collaboratively to improve access to pain care and dismantle the barriers preventing timely, appropriate and effective pain care for millions.
Neuralstem, Inc. announced that the first patients were dosed in Phase Ib of its ongoing trial to test the safety of NSI-189 in the treatment of major depressive disorder (MDD).
Public Health Week, April 7-13, annually highlights health promotion, disease prevention, and early intervention, but for the faculty and students at the Johns Hopkins University School of Nursing (JHUSON), every week is public health week.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christine C Rohl, Po Box 3539, Munster, IN 46321-0539 Ph: (219) 934-4200 | Christine C Rohl, 10010 Donald Powers Dr, Munster, IN 46321 Ph: (219) 934-4200 |
News Archive
American Oriental Bioengineering, Inc., ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced that 158 of the Company's drugs have been included in China's National (Medical) Insurance Catalog (the "2009 NIC").
The American Pain Foundation (APF), the nation's largest consumer advocacy organization for people in pain, released today a position statement imploring the medical community, regulators and concerned stakeholders to reaffirm their ethical commitment to the 76.5 million Americans—or one in four people—who struggle with pain, work collaboratively to improve access to pain care and dismantle the barriers preventing timely, appropriate and effective pain care for millions.
Neuralstem, Inc. announced that the first patients were dosed in Phase Ib of its ongoing trial to test the safety of NSI-189 in the treatment of major depressive disorder (MDD).
Public Health Week, April 7-13, annually highlights health promotion, disease prevention, and early intervention, but for the faculty and students at the Johns Hopkins University School of Nursing (JHUSON), every week is public health week.
› Verified 4 days ago
Konstantina Gardikiotes, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 9410 Calumet Ave Ste 101, Munster, IN 46321 Phone: 773-807-8510 | |
Jennifer Dawn Stone, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 9250 Columbia Ave Ste 2e, Munster, IN 46321 Phone: 219-595-0043 Fax: 219-237-2894 | |
Kathleen A Carlson, NURSE PRACTITIONER Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 761 45th St Ste 103, Munster, IN 46321 Phone: 219-922-3002 Fax: 219-922-3003 | |
Jennifer Lee Franklin, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 701 Superior Ave Ste 2700, Munster, IN 46321 Phone: 219-922-7168 Fax: 219-922-7170 | |
Olaide Avoseh, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 9128 Columbia Ave, Munster, IN 46321 Phone: 219-836-2730 | |
Brett Allen Milkevitch, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7905 Calumet Ave, Munster, IN 46321 Phone: 219-836-5800 Fax: 219-836-3048 | |
Jessica Rae Delgado, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 701 Superior Ave Ste 2500, Munster, IN 46321 Phone: 219-922-4081 Fax: 219-922-5880 |